The heat shock factor 1 (HSF1) as a latent target for prognosis and immunotherapy presents different performance in pan‐cancer, promoting oncogenesis and metastasis in some cancers (liver cancer and kidney cancer) while inhibiting oncogenesis and metastasis in some cancers (lung cancer and cholangiocarcinoma).4 Here, HSF1 is linked to cancer.